NCT02646644View on ClinicalTrials.gov

Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Neuroendocrine Tumors
Interventions
OTHER

Metastasized intestinal NET

This is an observational study

Trial Locations (1)

9713 GZ

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT02646644 - Heterogeneity of Metastatic Neuroendocrine Tumors as Determined With 18F-dihydroxyphenylalanine-PET /CT, a Retrospective Analysis | Biotech Hunter | Biotech Hunter